These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38769118)

  • 41. A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing's sarcoma cells, interacts with the EWS-FLI1 and partner proteins.
    Thangaretnam KP; Gopisetty G; Ramanathan P; Rajkumar T
    Sci Rep; 2017 Aug; 7(1):7172. PubMed ID: 28775288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An
    Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
    Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift.
    Bridge JA; Fidler ME; Neff JR; Degenhardt J; Wang M; Walker C; Dorfman HD; Baker KS; Seemayer TA
    Am J Surg Pathol; 1999 Feb; 23(2):159-65. PubMed ID: 9989842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetic control of the EWS‑FLI1 promoter in Ewing's sarcoma.
    Montoya C; Rey L; Rodríguez J; Fernández MJ; Troncoso D; Cañas A; Moreno O; Henríquez B; Rojas A
    Oncol Rep; 2020 Apr; 43(4):1199-1207. PubMed ID: 32323788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for DAX1/EWS-FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma.
    Watanabe M; Kosaka H; Sugawara M; Maemoto M; Ono Y; Uemori T; Shizu R; Yoshinari K
    Cancer Med; 2023 Apr; 12(8):9802-9814. PubMed ID: 36825574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AT-hook DNA-binding motif-containing protein one knockdown downregulates EWS-FLI1 transcriptional activity in Ewing's sarcoma cells.
    Kitagawa T; Kobayashi D; Baron B; Okita H; Miyamoto T; Takai R; Paudel D; Ohta T; Asaoka Y; Tokunaga M; Nakagawa K; Furutani-Seiki M; Araki N; Kuramitsu Y; Kobayashi M
    PLoS One; 2022; 17(10):e0269077. PubMed ID: 36194562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Detection of EWSR1 gene rearrangement by fluorescence in situ hybridization in bone and soft tissue tumors: clinical application evaluation and atypical signal analysis].
    Li L; Zhang M; Zhang TT; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):458-463. PubMed ID: 38678326
    [No Abstract]   [Full Text] [Related]  

  • 48. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.
    Le Deley MC; Delattre O; Schaefer KL; Burchill SA; Koehler G; Hogendoorn PC; Lion T; Poremba C; Marandet J; Ballet S; Pierron G; Brownhill SC; Nesslböck M; Ranft A; Dirksen U; Oberlin O; Lewis IJ; Craft AW; Jürgens H; Kovar H
    J Clin Oncol; 2010 Apr; 28(12):1982-8. PubMed ID: 20308673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathological Features of Three Rare
    Kosemehmetoglu K; Rekhi B; Erdem ZB; Yildiz AE; Comunoglu N
    Int J Surg Pathol; 2024 Oct; 32(7):1275-1285. PubMed ID: 38321863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a novel translocation producing an in-frame fusion of TAF15 and ETV4 in a case of extraosseous Ewing sarcoma revealed in the prenatal period.
    Picard C; Macagno N; Corradini N; Marec-Bérard P; Cabet S; Guibaud L; Viremouneix L; Raux S; Chotel F; Weinbreck N; Meurgey A; Karanian M; Pissaloux D; Tirode F; Dijoud F
    Virchows Arch; 2022 Oct; 481(4):665-669. PubMed ID: 35527322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiating Ewing's sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues.
    Lewis TB; Coffin CM; Bernard PS
    Mod Pathol; 2007 Mar; 20(3):397-404. PubMed ID: 17334332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ewing's sarcoma family of tumors of the maxillary sinus: a case report of multidisciplinary examination enabling prompt diagnosis.
    Tajima S; Ohkubo A; Yoshida M; Koda K; Nameki I
    Int J Clin Exp Pathol; 2015; 8(1):960-6. PubMed ID: 25755803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and B.
    Winter GE; Rix U; Lissat A; Stukalov A; Müllner MK; Bennett KL; Colinge J; Nijman SM; Kubicek S; Kovar H; Kontny U; Superti-Furga G
    Mol Cancer Ther; 2011 Oct; 10(10):1846-56. PubMed ID: 21768330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors.
    Jambhekar NA; Bagwan IN; Ghule P; Shet TM; Chinoy RF; Agarwal S; Joshi R; Amare Kadam PS
    Arch Pathol Lab Med; 2006 Dec; 130(12):1813-8. PubMed ID: 17149955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endometrial endometrioid carcinomas associated with Ewing sarcoma/peripheral primitive neuroectodermal tumor.
    Sinkre P; Albores-Saavedra J; Miller DS; Copeland LJ; Hameed A
    Int J Gynecol Pathol; 2000 Apr; 19(2):127-32. PubMed ID: 10782408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extraskeletal Ewing's sarcoma in a 67-year-old man.
    Hanaoka N; Goto T; Kasai T; Matsuura T; Nishisho T; Enishi T; Yasui N
    J Orthop Sci; 2011 Mar; 16(2):250-2. PubMed ID: 21327980
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle.
    Asami S; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
    Biol Pharm Bull; 2008 Mar; 31(3):391-4. PubMed ID: 18310898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications.
    Amaral AT; Manara MC; Berghuis D; Ordóñez JL; Biscuola M; Lopez-García MA; Osuna D; Lucarelli E; Alviano F; Lankester A; Scotlandi K; de Álava E
    PLoS One; 2014; 9(2):e85814. PubMed ID: 24498265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.
    Owen LA; Kowalewski AA; Lessnick SL
    PLoS One; 2008 Apr; 3(4):e1965. PubMed ID: 18414662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior.
    Tsuda Y; Dickson BC; Swanson D; Sung YS; Zhang L; Meyers P; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 May; 59(5):286-294. PubMed ID: 31756779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.